Eiger BioPharmaceuticals Funding: $7.1M Raised, Series A
Eiger BioPharmaceuticals is based in Palo Alto. It has raised $7.1M in total funding. Latest round: Series A. Backed by InterWest Partners, Vivo Ventures.
Eiger BioPharmaceuticals funding overview
Eiger BioPharmaceuticals is based in Palo Alto. Eiger BioPharmaceuticals has raised $7.1M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in February 2014. The round record for Eiger BioPharmaceuticals runs through 2014; nothing later has been disclosed. Investors on record include InterWest Partners, Vivo Ventures. 2 distinct backers are named across the disclosed rounds.
Eiger BioPharmaceuticals at a glance
Total raised
$7.1M
Latest round
Series A
Latest round date
February 2014
Headquarters
Palo Alto
Notable investors
InterWest Partners, Vivo Ventures
Frequently asked about Eiger BioPharmaceuticals funding
How much has Eiger BioPharmaceuticals raised?
Eiger BioPharmaceuticals has raised $7.1M in total disclosed funding across the rounds on record.
Who has invested in Eiger BioPharmaceuticals?
InterWest Partners, Vivo Ventures are named among the investors backing Eiger BioPharmaceuticals.
What was the latest Eiger BioPharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in February 2014.
Where is Eiger BioPharmaceuticals based?
Eiger BioPharmaceuticals is based in Palo Alto.
When did Eiger BioPharmaceuticals last raise?
The last disclosed Eiger BioPharmaceuticals round closed in February 2014 at Series A.
Totals shown for Eiger BioPharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Palo Alto and the investors behind them below.
Companies related to Eiger BioPharmaceuticals (22)
